Nymox Pharmaceutical Corporation

Pharmaceutical manufacturing.

🤖

AI Overview

With $390K in lobbying spend across 15 quarterly filings, Nymox Pharmaceutical Corporation is an active lobbying client. Their lobbying covers 1 issue area. Active from 2019 to 2022.

$390K
Total Spend
4
Years Active
1
Firms Hired
7
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2019$90K
2020$120K
2021$120K
2022$60K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Nymox Pharmaceutical Corporation disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Issues related to pharmaceutical development.

Issues related to drug development.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.